RRAD and neoplasm: High expression of FOSB+, NEAT1+, or XIST+ tumor cell-associated genes such as FSTL3, VTN, PAPPA, CCN1, RRAD, and GPRIN3 may predict poor survival in patients with LUSC, suggesting that these genes act as prognosis biomarkers.